Emerging frontiers and challenges of artificial intelligence in PSMA-PET imaging: pioneering a new chapter in prostate cancer care.

TL;DR

The evolving role of nuclear medicine physicians and radiologists as integrators of AI-derived biomarkers are highlighted, who validate AI outputs for high-stakes decisions, retain interpretive authority for complex cases, and oversee quality assurance, ensuring that AI augments rather than replaces specialist expertise.